These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8965581)

  • 1. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Computerize drug handling! Scrutiny of drug prescriptions at four emergency hospitals show big shortages].
    Gardulf A; Bergman U; George C; Nordström G
    Lakartidningen; 2005 May 30-Jun 5; 102(22):1732-4, 1736-7. PubMed ID: 15987051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance in the provision of hospital care. Medication process: who's responsible?
    Beste DF; de Leon RF
    Hospitals; 1974 Mar; 48(5):97-100. PubMed ID: 4815748
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of quality assurance in hospital pharmacy.
    Oakley RS; Bradham DD
    Am J Hosp Pharm; 1983 Jan; 40(1):53-63. PubMed ID: 6823989
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug committee--an example of a quality circle].
    Hammershøy E; Christensen U; Christensen I
    Ugeskr Laeger; 1991 Aug; 153(34):2330-3. PubMed ID: 1897040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Safer drug administration with computerized drug records. Solution for many of the old-time problems--but new risks appear].
    Sellgren SF; Ringertz B
    Lakartidningen; 2010 Nov 3-9; 107(44):2723-5. PubMed ID: 21179880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].
    Nyman K; Bergens A; Björin AS; Guterstam P; Nyrén O; Jansson U; Wettermark B; Bergman U
    Lakartidningen; 2001 Jan; 98(3):160-4. PubMed ID: 11271576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assurance: ensuring pharmacy personnel follow procedures for handling cytotoxic drugs.
    Scott BE; White SJ; Matthews T
    Hosp Pharm; 1987 Jan; 22(1):45-9. PubMed ID: 10280293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antibiotic utilization committee.
    Zeman BT; Pike M; Samet C
    Hospitals; 1974 Apr; 48(8):73-6. PubMed ID: 4820315
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug committees in hospitals].
    Flatberg P
    Tidsskr Nor Laegeforen; 1975 Jan; 95(1):36-7. PubMed ID: 1111160
    [No Abstract]   [Full Text] [Related]  

  • 13. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care and institutional pharmacy practice in Japan.
    Tsubaki T; Iga T; Chandler MH
    Am J Hosp Pharm; 1994 Feb; 51(4):535-8. PubMed ID: 8017427
    [No Abstract]   [Full Text] [Related]  

  • 15. 10 targets for reducing adverse drug events. Institute for Healthcare Improvement.
    Qual Lett Healthc Lead; 1999 Mar; 11(3):13-25. PubMed ID: 10351585
    [No Abstract]   [Full Text] [Related]  

  • 16. Filling and refilling practices with diazepam and methyldopa.
    Scrivens JJ; Weber C; Sather M; Geck W
    Hosp Formul; 1979 Sep; 14(9):830-1,834-6,838. PubMed ID: 10243909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Are the recommendations of the drug committee followed? A comparison of the prescribing pattern of anti-angina drugs in general practice and hospitals in relation to the recommendations].
    Salomonsen H; Beierholm V
    Ugeskr Laeger; 1991 Aug; 153(34):2333-5. PubMed ID: 1897041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifaceted approach to medication use policy development: the restriction of meperidine.
    Vermeulen LC; Bollinger KA; Antonopoulos J; Meek PD; Goshman LM; Ploetz PA
    Pharm Pract Manag Q; 1997 Jan; 16(4):66-75. PubMed ID: 10164161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. American Society of Hospital Pharmacists. Product selection survey.
    Am J Hosp Pharm; 1972 Jun; 29(6):506. PubMed ID: 5035970
    [No Abstract]   [Full Text] [Related]  

  • 20. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.